NASDAQ:AKER

Akers Biosciences Price Target, Predictions & Analyst Ratings

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Today's Range: $2.21
▼
$2.36
50-Day Range: $2.47
▼
$4.59
52-Week Range: $1.65
▼
$6.97

Volume: 29,438 shs
Average Volume: 769,876 shs
Market Capitalization: $38.97 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 0.3

Akers Biosciences (NASDAQ:AKER) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Sell
Based on 2 Analyst Ratings

Analyst Price Target Consensus

N/A

Type	Current 5/16/21 to 5/16/22	1 Month Ago 4/16/21 to 4/16/22	3 Months Ago 2/15/21 to 2/15/22	1 Year Ago 5/16/20 to 5/16/21
Consensus Rating	Sell	Sell	Sell	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Price Target Upside	N/A	N/A	N/A	N/A

Get Akers Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AKER and its competitors with MarketBeat's FREE daily newsletter.

Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Akers Biosciences (NASDAQ:AKER) vs. Its Competitors

Type	Akers Biosciences	Medical Companies	S&P 500
Consensus Rating Score	1.00	2.72	2.52
Consensus Rating	Sell	Buy	Buy
Price Target Upside		463.26% Upside	27.06% Upside
News Sentiment Rating	Neutral News	Neutral News	Neutral News
MarketBeat Community Rating	Outperform Votes 307 72.92% Underperform Votes 114 27.08%	Avg. Outperform Votes 171 67.32% Avg. Underperform Votes 83 32.68%	Avg. Outperform Votes 838 69.31% Avg. Underperform Votes 371 30.69%

Akers Biosciences (NASDAQ:AKER) Analyst Ratings History

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
1/17/2022	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Sell
1/3/2022	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Sell

(Data available from 5/16/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Akers Biosciences (NASDAQ:AKER) Analyst Ratings Frequently Asked Questions

What is Akers Biosciences's consensus rating?: According to the issued ratings of 2 analysts in the last year, the consensus rating for Akers Biosciences stock is Sell based on the current 2 sell ratings for AKERthe . Learn more on AKER's analyst rating history.
Do Wall Street analysts like Akers Biosciences more than its competitors?: Analysts like Akers Biosciences stock less than the stock of other Medical companies. The consensus rating for Akers Biosciences is Sell while the average consensus rating for medical companies is Buy. Learn more on how AKER compares to other companies.
Do MarketBeat users like Akers Biosciences more than its competitors?: MarketBeat users like Akers Biosciences stock more than the stock of other Medical companies. 72.92% of MarketBeat users gave Akers Biosciences an outperform vote while medical companies recieve an average of 67.32% outperform votes by MarketBeat users.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources